Remove Artificial Inteligence Remove Artificial Intelligence Remove Biotech Remove Technical Review
article thumbnail

Biotech Boom: Executive Search Strategies in Life Sciences

N2Growth Blog

With the constant advancements in technology and research, businesses in this sector require leaders who possess a deep understanding of the scientific landscape and the business acumen to drive growth and innovation. The life sciences industry is known for its unique challenges in recruiting and hiring.

Biotech 175
article thumbnail

The Week’s 10 Biggest Funding Rounds: Massive Rounds By Cruise And AlphaSense Lead Way

Crunchbase News

AI, biotech, space tech and cybersecurity also saw good-sized raises. Then, late last year, Cruise suspended its self-driving taxi program across the country after losing its permit to operate in San Francisco due to an incident with a pedestrian. Alzheon , $100M, biotech: Alzheon was the next biotech to raise big this week.

Biotech 71
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Will enterprises soon keep their best gen AI use cases under wraps?

CIO

Normally, a CCO develops ideas about what the market needs and communicates them to a design team, which produces sketches to then be reviewed by the CCO. But what we’re learning from public announcements like these might just scratch the surface of gen AI use cases for the enterprise.

article thumbnail

TechCrunch+ roundup: 7 VCs who are taking pitches, AI best practices, zero-based budgeting

TechCrunch

Best practices for leveraging artificial intelligence and machine learning in 2023 Zero-based budgeting: A proven framework for extending runway Image Credits: Getty Images It’s critical to make every dollar count in this environment, but pulling back too much in the wrong places can reduce momentum across your entire organization. “The

Budget 230
article thumbnail

Digital biomarkers are healthcare’s next frontier

TechCrunch

Sunny Kumar, MD, MBA is a partner at GSR Ventures, an early-stage venture capital firm focused on healthcare technology with more than $3.5 Neurodegenerative disease is a major target for digital biomarker development due to a lack of easily accessible indicators that can help providers diagnose and manage these conditions.

article thumbnail

The ‘Great Retraining’: IT upskills for the future

CIO

When the timing was right, Chavarin honed her skills to do training and coaching work and eventually got her first taste of technology as a member of Synchrony’s intelligent virtual assistant (IVA) team, writing human responses to the text-based questions posed to chatbots.

article thumbnail

As Funding Fell, So Did The Number Of New Female-Founded Unicorn Startups

Crunchbase News

The technology gives districts visibility so they can optimize routes and even deliver real-time updates to parents. Others include: Imbue , a startup that trains foundational models to develop AI agents, landed $200 million in a September Series B round at a valuation of more than $1 billion. Illustration: Dom Guzman